Cargando…

Purinergic transmission in brain tumors and its impact on drug development

Detalles Bibliográficos
Autores principales:	Abbracchio, Maria, Ceruti, Stefania, Lecca, Davide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2015
Materias:	Lecture Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4797922/ https://www.ncbi.nlm.nih.gov/pubmed/27386173 http://dx.doi.org/10.1186/2193-1801-4-S1-L10

Ejemplares similares

Pathophysiological Role of Purines and Pyrimidines in Neurodevelopment: Unveiling New Pharmacological Approaches to Congenital Brain Diseases
por: Fumagalli, Marta, et al.
Publicado: (2017)

Purinergic Receptors on Oligodendrocyte Progenitors: Promising Targets for Myelin Repair in Multiple Sclerosis?
por: Lecca, Davide, et al.
Publicado: (2021)

Purinergic signalling: from discovery to current developments
por: Burnstock, Geoffrey
Publicado: (2014)

Editorial: Purinergic Signaling in Health and Disease
por: Boué-Grabot, Eric, et al.
Publicado: (2020)

The Purinergic System and Glial Cells: Emerging Costars in Nociception
por: Magni, Giulia, et al.
Publicado: (2014)

Purple Corn Extract as Anti-allodynic Treatment for Trigeminal Pain: Role of Microglia
por: Magni, Giulia, et al.
Publicado: (2018)

P1 receptors and cytokine secretion
por: Abbracchio, Maria P., et al.
Publicado: (2007)

Roles of P2 receptors in glial cells: focus on astrocytes
por: Abbracchio, Maria P., et al.
Publicado: (2006)

Discovery of nitric oxide and cyclic GMP in cell signaling and their role in drug development
por: Murad, Ferid
Publicado: (2012)

Opposite effects of uracil and adenine nucleotides on the survival of murine cardiomyocytes
por: Mazzola, Alessia, et al.
Publicado: (2008)

In Memoriam Geoffrey Burnstock: Creator of Purinergic Signaling
por: Verkhratsky, Alexei, et al.
Publicado: (2020)

The role of microvascular endothelial WNT signaling the formation of the blood brain barrier
por: Lampugnani, Maria Grazia, et al.
Publicado: (2015)

ApoER2 trafficking, processing and signaling and its participation in neurodegeneration
por: Marzolo, María-Paz
Publicado: (2012)

The Distribution of GPR17-Expressing Cells Correlates with White Matter Inflammation Status in Brain Tissues of Multiple Sclerosis Patients
por: Angelini, Jacopo, et al.
Publicado: (2021)

Drug therapy: preparation, administration and disposal
por: Diano, G, et al.
Publicado: (2010)

Prevention of adverse events in the administration of drugs
por: Diano, G, et al.
Publicado: (2010)

Phenomic technologies in drug discovery of neglected diseases
por: Nehrbass, Ulf
Publicado: (2011)

Altered Purinergic Signaling in Neurodevelopmental Disorders: Focus on P2 Receptors
por: Boccazzi, Marta, et al.
Publicado: (2023)

Neurochemical changes in different brain regions induced by PACAP - relations to neuroprotection
por: Reglodi, Dora, et al.
Publicado: (2015)

ApoE and apoE receptors in brain lipid metabolism and AD
por: Bu, Guojun
Publicado: (2012)

Prevention of cognitive deficits in Alzheimer’s mouse model by elevating brain magnesium
por: Liu, Guosong
Publicado: (2012)

Anti-inflammatory activities of carbon monoxide-releasing molecules (CO-RMs) in the brain
por: Motterlini, Roberto, et al.
Publicado: (2015)

Reticulon 3 aggregation and its role in the formation of dystrophic neurites
por: Yan, Riqiang
Publicado: (2012)

The impact of comorbidity on medication adherence and therapeutic goals
por: Corsonello, A, et al.
Publicado: (2010)

Imaging of α2C-adrenoceptors in the living brain: a method to monitor noradrenaline release?
por: Scheinin, Mika, et al.
Publicado: (2015)

Disruption of specific GDNF receptor subtype signaling impairs cortical neuronal survival in Alzheimer’s brains
por: Konishi, Yoshihiro, et al.
Publicado: (2012)

The molecular control of GnRH neuron development
por: Cariboni, Anna, et al.
Publicado: (2015)

Enteric vaccines for the developing world: challenges and prospects
por: Czerkinsky, Cecil
Publicado: (2011)

Shortening the drug discovery pipeline: small molecule high content screening for lead discovery in neglected disease
por: Cechetto, Jonathan, et al.
Publicado: (2011)

Lupin Peptide T9 (GQEQSHQDEGVIVR) Modulates the Mutant PCSK9(D374Y) Pathway: in vitro Characterization of its Dual Hypocholesterolemic Behavior
por: Lammi, Carmen, et al.
Publicado: (2019)

Recent developments in tau-based therapeutics for Alzheimer’s disease and related dementsia
por: Medina, Miguel
Publicado: (2015)

LiEIF and its recombinant polypeptides enhance the maturation of mouse dendritic cells and the production of the protective IL-12 cytokine
por: Koutsoni, O, et al.
Publicado: (2011)

Ankrd11 is a chromatin regulator involved in autism that is essential for neural development
por: Voronova, Anastassia, et al.
Publicado: (2015)

Great challenges to PMTCT in the South: the role of the developed nations in supporting strategies that work
por: Onyango, Dorothy
Publicado: (2008)

Networking the Leishmania research community for the development of novel anti-leishmanial intervention strategies
por: Späth, Gerald F
Publicado: (2011)

Reacquisition of cocaine conditioned place preference and its inhibition by previous social interaction: Neurochemical and electrophysiological correlates in the nucleus accumbens corridor
por: Saria, Alois, et al.
Publicado: (2015)

WNT signaling in midbrain dopaminergic neuron development and cell replacement therapies for Parkinson’s disease
por: Arenas, Ernest, et al.
Publicado: (2015)

Application of personal-oriented digital technology in preventing transmission of COVID-19, China
por: Pan, Xiao-Ben
Publicado: (2020)

Development of a cell-based high throughput assay system and IN-house image analysis software for screening of active compounds against dengue virus
por: Cruz, Deu John M, et al.
Publicado: (2011)

Cardiomyocyte death induced by ischaemic/hypoxic stress is differentially affected by distinct purinergic P2 receptors
por: Cosentino, Simona, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_g3hgne10nq5g32kq3tnv15mt8k